I131 reinforces antitumor activity of metuximab by reversing epithelial –mesenchymal transition via VEGFR‐2 signaling in hepatocellular carcinoma

In conclusion, our results elucidated the mechanism underlying the anti‐HCC effects of I131‐mab and provided a theoretical foundation for the clinical application of I131‐mab.

Source: Genes to Cells - November 1, 2017 Category: Genetics & Stem Cells Authors: Lu Wu, Bin Sun, Xuejing Lin, Chunying Liu, Haihua Qian, Lei Chen, Yefa Yang, Feng Shen, Changqing Su Tags: ORIGINAL ARTICLE Source Type: research